FIELD OF APPLICATIONDETAILS
Generic Name
Bisoxatin
Active Ingredient
Bisoxatin
Drug Category
Gastroenterology
Drug Class
Palliative treatment, Immunosuppressive therapy
FDA Approval Status
Not approved

Bisoxatin Overview

Bisoxatin (often formulated as bisoxatin acetate) is a synthetic diphenylmethane derivative. Chemically, it belongs to the class of organic compounds known as diphenylmethanes within the benzenoids superclass. Structurally, it features a 1,4-benzoxazin-3-one core fused within a diphenylmethane-like framework carrying phenolic hydroxyl groups.

In clinical gastroenterology and pharmacology, Bisoxatin is classified as a contact stimulant laxative (ATC code A06AB09). It is indicated for the short-term treatment of acute and chronic constipation (in the absence of mechanical bowel obstruction) and for pre-operative or pre-diagnostic bowel preparation to cleanse the colon prior to surgical or endoscopic procedures. Marketed internationally in select European nations (such as Belgium under the trade name Wylaxine), Bisoxatin acts directly on the colonic mucosa to stimulate peristaltic contractions and inhibit electrolyte absorption.

What Is Bisoxatin and How Does It Work?

Bisoxatin is a small molecule diphenylmethane derivative that functions primarily as a localized colonic contact stimulant laxative.

Its primary physiological and mucosal mechanisms include:

  • Direct Stimulation of Colonic Myenteric Plexus: Following oral administration, Bisoxatin directly contacts the mucosal lining of the large intestine, stimulating intramural nerve plexuses (myenteric plexus) to enhance propulsive colonic peristalsis.
  • Inhibition of Intestinal Fluid & Ion Absorption: It directly inhibits the active mucosal absorption of water, sodium (Na+), and chloride (Cl−) ions across the colonic epithelium.
  • Stimulation of Luminal Fluid Secretion: By altering epithelial transport and permeability, Bisoxatin promotes the net secretion of water and electrolytes into the intestinal lumen, increasing stool volume, softening stool consistency, and accelerating transit time.

Is Bisoxatin FDA Approved?

No, Bisoxatin is not approved by the US FDA for commercial distribution or clinical prescription in the United States. It has never received New Drug Application (NDA) approval. However, it has been authorized and marketed across select European jurisdictions (most notably in Belgium under the trade name Wylaxine) as a short-term contact stimulant laxative for constipation management and pre-procedural bowel cleansing.

What Is Bisoxatin Used For?

  • Symptomatic treatment of short-term or chronic constipation in patients without mechanical intestinal obstruction.
  • Bowel preparation (colon cleansing) prior to abdominal surgery, radiological imaging, or colonoscopy.

Before Taking Bisoxatin: Contraindications & Precautions

Strictly contraindicated in mechanical bowel obstruction, ileus, intestinal strictures, bowel perforation, acute IBD flares, acute appendicitis, severe dehydration, or undiagnosed abdominal pain. Minimal systemic absorption data are available; avoid during pregnancy and lactation unless explicitly directed by a physician.

Who Should Not Take Bisoxatin?

  • Individuals with known or suspected mechanical bowel obstruction, ileus, intestinal strictures, or bowel perforation.
  • Patients with acute inflammatory bowel conditions, such as active Crohn’s disease, severe ulcerative colitis, or acute appendicitis.
  • Individuals with severe undiagnosed abdominal pain, nausea, or vomiting.
  • Patients with severe dehydration or systemic electrolyte collapse.
  • Individuals with a documented hypersensitivity to Bisoxatin, diphenylmethane derivatives, or formulation excipients.

Bisoxatin, Pregnancy & Fertility

Systemic absorption following oral administration is low to moderate, with metabolites eliminated primarily by renal excretion. Adequate, well-controlled reproductive safety studies in pregnant women are lacking. Bisoxatin should be avoided during pregnancy unless explicitly directed by a physician. Caution is advised for nursing mothers.

Tell Your Doctor Before Taking Bisoxatin

Inform your gastroenterologist or physician if you have a history of chronic constipation, renal impairment, inflammatory bowel disease, or severe electrolyte disturbances. Disclose all concurrent prescription medications, particularly cardiac glycosides, diuretics, or antiarrhythmic agents.

Bisoxatin Dosage & Administration

Formulated as oral tablets or liquids. Standard adult international dosing for constipation ranges from 120 mg to 240 mg taken orally once daily at bedtime with a full glass of water, producing a bowel movement within 6 to 12 hours.

Standard Bisoxatin Dosing

  • Adult Oral Dosing (Constipation): Standard international adult therapeutic dosages typically range from 120 mg to 240 mg taken orally once daily at bedtime or as directed by a physician.
  • Surgical / Pre-Diagnostic Bowel Preparation: Administered as a single higher dose or split doses on the day preceding the procedure, accompanied by abundant fluid intake.

How Bisoxatin Is Administered

  • Administered via the oral route in tablet or liquid form.
  • Take oral doses at bedtime to produce a comfortable bowel movement the following morning (typically within 6 to 12 hours).
  • Swallow tablets whole with a full glass of water.

Bisoxatin Clinical Efficacy & Research

Clinical evidence in gastroenterology demonstrates that Bisoxatin is an effective contact stimulant laxative capable of rapidly inducing colonic evacuation. Comparative clinical evaluations show that Bisoxatin provides reliable peristaltic stimulation similar to other diphenylmethane contact laxatives (such as bisacodyl and sodium picosulfate). It effectively cleanses the colon prior to surgical or radiological procedures while providing predictable relief from acute constipation.

Bisoxatin Side Effects & Safety Profile

BLACK BOX WARNING

Bisoxatin does not carry an FDA Black Box Warning.

Common adverse effects include abdominal cramping, intestinal colic, flatulence, diarrhea, nausea, and perianal irritation. Serious risks include severe dehydration, hypokalemia, and cathartic colon or laxative dependence with prolonged use. It holds no FDA Black Box Warning.

Common Bisoxatin Side Effects

  • Abdominal cramping, intestinal colic, and flatulence.
  • Diarrhea, loose stools, and nausea.
  • Perianal irritation secondary to frequent bowel movements.

Serious Bisoxatin Adverse Events

  • Severe Electrolyte Imbalance & Dehydration: Excessive fluid loss leading to hypokalemia, hyponatremia, and secondary muscle weakness or cardiac rhythm alterations.
  • Cathartic Colon & Laxative Dependence: Prolonged, chronic overuse causing loss of normal colonic smooth muscle tone and neuromuscular damage to the myenteric plexus.
  • Severe hypersensitivity or cutaneous allergic reactions.

Managing Bisoxatin Side Effects

Ensure high daily fluid intake while taking stimulant laxatives. If severe abdominal pain, persistent diarrhea, or lightheadedness occurs, discontinue medication and consult a healthcare provider.

Bisoxatin Drug Interactions & What to Avoid

Induce hypokalemia that significantly increases digoxin toxicity and arrhythmia risks. Concurrent diuretics or corticosteroids compound potassium loss. Accelerated GI transit blunts mucosal absorption of co-administered oral drugs. Maintain adequate fluid intake and avoid taking heavy meals.

Bisoxatin Drug-Drug Interactions

  • Cardiac Glycosides (e.g., Digoxin): Bisoxatin-induced potassium loss increases the risk of digoxin toxicity and life-threatening cardiac arrhythmias.
  • Diuretics (e.g., Furosemide, Hydrochlorothiazide) & Corticosteroids: Concomitant use accelerates renal and intestinal potassium loss, compounding hypokalemia risks.
  • Other Oral Medications: Accelerated gastrointestinal transit time can decrease the mucosal absorption and systemic efficacy of co-administered oral drugs.

Bisoxatin, Food & Alcohol

Systemic food interactions are minimal, though taking stimulant laxatives with heavy meals can worsen abdominal cramps. Maintain generous fluid intake.

Bisoxatin: Missed Dose, Overdose & Storage

If a dose is missed, take it as soon as remembered if bowel evacuation is desired. Acute overdose causes severe abdominal cramps, explosive watery diarrhea, hypokalemia, and dehydration, requiring emergency IV fluid rehydration. Store oral formulations between 15°C and 30°C (59°F–86°F).

Missed Dose of Bisoxatin

If taking on a daily schedule and a dose is missed, take it as soon as remembered if bowel evacuation is desired. If it is close to the time for your next scheduled dose, skip the missed dose. Do not take double doses.

Bisoxatin Overdose & Emergency

Acute overdose causes severe, painful abdominal cramps, explosive watery diarrhea, massive fluid loss, hypokalemia, and cardiovascular collapse. Seek immediate emergency medical care for intravenous fluid rehydration and electrolyte replacement.

How to Store Bisoxatin

Store oral formulations at controlled room temperature between 15°C and 30°C. Protect from excessive light, heat, and moisture. Keep strictly out of reach of children.

Bisoxatin Patient Management & Monitoring

Rule out mechanical bowel obstruction or surgical abdomen prior to initiating therapy. Monitor hydration status, stool frequency, and serum electrolytes in elderly patients or those on concurrent diuretics. Do not use it continuously for longer than 7 consecutive days.

Tests Before Starting Bisoxatin

  • Baseline clinical evaluation to exclude mechanical intestinal obstruction or acute surgical abdomen.
  • Baseline serum electrolytes (potassium, sodium) in elderly or chronically ill patients.

Monitoring During Bisoxatin Treatment

Monitor bowel movement frequency, stool consistency, and hydration status during short-term use. Avoid continuous unmonitored use exceeding 7 days.

Bisoxatin Do’s and Don’ts

  • Do take doses at bedtime with a full glass of water.
  • Do maintain adequate daily fluid intake to prevent dehydration.
  • Do not use chronically for longer than 7 consecutive days without medical supervision.
  • Do not give to patients with suspected bowel obstruction.

Frequently Asked Questions

What exact type of chemical is Bisoxatin?

Bisoxatin is a small molecule synthetic diphenylmethane derivative carrying phenolic hydroxyl groups.

How does Bisoxatin promote bowel movements?

It directly stimulates the nerves in the intestinal wall to increase colon contraction while blocking water and sodium absorption in the gut.

Is Bisoxatin approved by the US FDA?

No, Bisoxatin is not approved by the US FDA, but it is approved in select European countries like Belgium under the brand name Wylaxine.

How long does Bisoxatin take to work?

When taken at bedtime, it typically produces a bowel movement within 6 to 12 hours.

Can Bisoxatin be used long term for constipation?

No, stimulant laxatives should not be used continuously for more than 7 days to avoid laxative dependency and electrolyte depletion.

What is the primary risk of taking too much Bisoxatin?

The primary risks of overdose are severe watery diarrhea, dehydration, and dangerous drops in blood potassium levels (hypokalemia).

Is Bisoxatin used before surgery?

Yes, it is indicated for pre-operative colon preparation to ensure the bowel is thoroughly cleansed before abdominal surgery.

References

  • DrugBank Database – Bisoxatin Clinical Profile (DB09219)
  • Classyfire Database – Diphenylmethanes Chemical Taxonomy Profile

The detailed medical and chemical information provided on this specific web page is intended strictly for educational and informational purposes regarding complex pharmacological mechanisms. It absolutely does not constitute professional medical advice, medical diagnosis, or specific treatment recommendations. Always consult a licensed healthcare provider before making any personal decisions regarding complex medical conditions, medication adjustments, or dietary changes.